期刊文献+

毛霉病的治疗 被引量:8

Treatment of mueormyeosis
下载PDF
导出
摘要 毛霉病是一种致死性真菌感染,是由毛霉目中的致病真菌感染所致,常侵犯中枢神经系统、肺、胃肠道、皮肤、眼眶和鼻窦等部位。毛霉病易侵犯血管,引起血栓和周围组织坏死,一旦发生,常危及生命。目前毛霉病的治疗比较困难,治疗的关键在于早期诊断、尽可能去除潜在的易感因素、适当的外科清创和恰当的抗真菌治疗。外科清创能提高患者的痊愈率,抗真菌治疗包括多种抗真菌药的使用(单用或联用),另外,还可给予高压氧和细胞因子等辅助治疗。 Mucormycosis is a kind of lethal infection caused by any fungus in the order Mucorales. It often involves the central nervous system, lungs, gastrointestinal tract, skin, orbit and paranasal sinuses. The hallmark of this disease is angioinvasion, thrombosis and tissue necrosis. Treatment of the disease is often difficult. The priaciples of treating mucormycosis include prompt diagnosis, removal of the underlying predisposing factors, if any, appropriate surgical debridement of infected tissue, and effective antifungal therapy. Surgical debridement can improve the cure rate. Antifungal therapy may he given with single or multiple antifungal agents. Furthermore, it is feasible to use adjunctive therapies such as hyperbaric oxygen therapy and cytokine therapy.
出处 《国际皮肤性病学杂志》 2007年第1期16-18,共3页 International Journal of Dermatology and Venereology
关键词 毛霉菌病 治疗 致死性真菌感染 抗真菌治疗 Mucormycosis Therapy
  • 相关文献

参考文献21

  • 1Nithyanandam S,Jacob MS,Battu RR,et al.Rhino-orbito-cerebral mucormycosis.A retrospective analysis of clinical features and treatment outcomes.Indian J Ophthalmol,2003,51(3):231-236.
  • 2Hofman V,Castillo L,Betis F,et al.Usefulness of frozen section in rhinocerebral mucormycosis diagnosis and management.Pathology,2003,35(3):212-216.
  • 3Spellberg B,Edwards J Jr,Ibrahim A.Novel perspectives on mucormycosis:pathophysiology,presentation,and management.Clin Microbiol Rev,2005,18(3):556-569.
  • 4Petrikkos G,Skiada A,Sambatakou H,et al.Mucormycosis:ten-year experience at a tertiary-care center in Greece.Eur J Clin Microbiol Infect Dis,2003,22(12):753-756.
  • 5Tedder M,Spratt JA,Anstadt MP,et al.Pulmonary mucormycosis:results of medical and surgical therapy.Ann Thorac Surg,1994,57(4):1044-1050.
  • 6Adam RD,Hunter G,DiTomasso J,et al.Mucormycosis:emerging prominence of cutaneous infections.Clin Infect Dis,1994,19(1):67-76.
  • 7Kerr OA,Bong C,Wallis C,et al.Primary cutaneous mucormycosis masquerading as pyoderma gangrenosum.Br J Dermatol,2004,150(6):1212-1213.
  • 8Oh D,Notrica D.Primary cutaneous mucormycosis in infants and neonates:case report and review of the literature.J Pediatr Surg,2002,37(11):1607-1611.
  • 9Ibrahim AS,Avanessian V,Spellberg B,et al.Liposomal amphotericin B,and not amphotericin B deoxycholate,improves survival of diabetic mice infected with Rhizopus oryzae.Antimicrob Agents Chemother,2003,47(10):3343-3344.
  • 10Gleissner B,Schilling A,Anagnostopolous I,et al.Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma,2004,45(7):1351-1360.

同被引文献44

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部